Literature DB >> 28275199

Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage.

Teddy Y Wu1, Gagan Sharma1, Daniel Strbian1, Jukka Putaala1, Patricia M Desmond1, Turgut Tatlisumak1, Stephen M Davis1, Atte Meretoja2.   

Abstract

BACKGROUND AND
PURPOSE: Edema may worsen outcome after intracerebral hemorrhage (ICH). We assessed its natural history, factors influencing growth, and association with outcome.
METHODS: We estimated edema volumes in ICH patients from the Helsinki ICH study using semiautomated planimetry. We assessed the correlation between edema extension distance (EED) and time from ICH onset, creating an edema growth trajectory model up to 3 weeks. We interpolated expected EED at 72 hours and identified clinical and imaging characteristics associated with faster edema growth. Association of EED and mortality was assessed using logistic regression adjusting for predictors of ICH outcome.
RESULTS: From 1013 consecutive patients, 861 were included. There was a strong inverse correlation between EED growth rate (cm/d) and time from onset (days): EED growth=0.162*days exp(-0.927), R2=0.82. Baseline factors associated with larger than expected EED were older age (71 versus 68; P=0.002), higher National Institutes of Health Stroke Scale score (14 versus 8; P<0.001), and lower Glasgow Coma scale score (13 versus 15; P<0.001), larger ICH volume (19.7 versus 12.7 mL; P<0.001), larger initial EED (0.42 versus 0.30; P<0.001), irregularly shaped hematoma (55% versus 42%; P<0.001), and higher glucose (7.6 versus 6.9 mmol/L; P=0.001). Patients with faster edema growth had more midline shift (50% versus 31%; P<0.001), herniation (12% versus 4%; P<0.001), and higher 6-month (46% versus 26%; P<0.001) mortality. In the logistic regression model, higher-than-expected EED was associated with 6-month mortality (odds ratio, 1.60; 95% confidence interval, 1.04-2.46; P=0.032).
CONCLUSIONS: Edema growth can be readily monitored and is an independent determinant of mortality after ICH, providing an important treatment target for strategies to improve patient outcome.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cerebral hemorrhage; edema; mortality; natural history; stroke

Mesh:

Year:  2017        PMID: 28275199     DOI: 10.1161/STROKEAHA.116.014416

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

Review 1.  Perihematomal edema: Implications for intracerebral hemorrhage research and therapeutic advances.

Authors:  Magdy Selim; Casey Norton
Journal:  J Neurosci Res       Date:  2018-12-21       Impact factor: 4.164

2.  Bedside Ultrasound After Decompressive Craniectomy: A New Standard?

Authors:  Tobias Bobinger; Hagen B Huttner; Stefan Schwab
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

3.  Serial quantitative neuroimaging of iron in the intracerebral hemorrhage pig model.

Authors:  Muhammad E Haque; Refaat E Gabr; Xiurong Zhao; Khader M Hasan; Andrew Valenzuela; Ponnada A Narayana; Shun-Ming Ting; Guanghua Sun; Sean I Savitz; Jaroslaw Aronowski
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-02       Impact factor: 6.200

4.  Perihematomal Edema After Intracerebral Hemorrhage in Patients With Active Malignancy.

Authors:  Aaron M Gusdon; Paul A Nyquist; Victor M Torres-Lopez; Audrey C Leasure; Guido J Falcone; Kevin N Sheth; Lauren H Sansing; Daniel F Hanley; Rachna Malani
Journal:  Stroke       Date:  2019-11-20       Impact factor: 7.914

5.  Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage: A Safety and Tolerability Study.

Authors:  Jesse J Corry; Ganesh Asaithambi; Arif M Shaik; Jeffrey P Lassig; Emily H Marino; Bridget M Ho; Amy L Castle; Nilanjana Banerji; Megan E Tipps
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

6.  Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.

Authors:  Audrey C Leasure; Adnan I Qureshi; Santosh B Murthy; Hooman Kamel; Joshua N Goldstein; Kyle B Walsh; Daniel Woo; Fu-Dong Shi; Hagen B Huttner; Wendy C Ziai; Daniel F Hanley; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth
Journal:  Stroke       Date:  2019-07-05       Impact factor: 7.914

7.  Statins and perihemorrhagic edema in patients with spontaneous intracerebral hemorrhage.

Authors:  Jens Witsch; Fawaz Al-Mufti; E Sander Connolly; Sachin Agarwal; Kara Melmed; David J Roh; Jan Claassen; Soojin Park
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

Review 8.  [Current treatment concepts in intracerebral hemorrhage].

Authors:  H B Huttner; J B Kuramatsu
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-10-12       Impact factor: 0.840

9.  Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.

Authors:  Isabel Charlotte Hostettler; Matthew J Morton; Gareth Ambler; Nabila Kazmi; Tom Gaunt; Duncan Wilson; Clare Shakeshaft; H R Jäger; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Lip; Martin M Brown; Keith Muir; Henry Houlden; Diederik O Bulters; Ian Galea; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-01-10       Impact factor: 10.154

10.  Oedema extension distance in intracerebral haemorrhage: Association with baseline characteristics and long-term outcome.

Authors:  Robert Hurford; Andy Vail; Calvin Heal; Wendy C Ziai; Jesse Dawson; Santosh B Murthy; Xia Wang; Craig S Anderson; Daniel F Hanley; Adrian R Parry-Jones
Journal:  Eur Stroke J       Date:  2019-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.